NovoCure said the FDA issued a Not Approvable Letter for its PMA seeking clearance of TTFields in brain metastases from non-small cell lung cancer. The decision

BWB News TV • 2026-11-09 13:36 UTC • By Billy Odell Tucker-Robinson

NovoCure said the FDA issued a Not Approvable Letter for its PMA seeking clearance of TTFields in brain metastases from non-small cell lung cancer. The decision is a setback to the company’s push to expand its oncology portfolio.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly